Insilico Medicine

Insilico Medicine is a clinical-stage biotechnology company leveraging generative AI to discover and develop novel drugs. They integrate genomics, big data, and deep learning to identify new targets, generate molecular structures, and predict clinical trial outcomes, significantly speeding up the drug discovery process. Their platforms aim to bring innovative therapies to patients faster and more efficiently.